Rose AMC, Mueller JE, Gerstl S, Njanpop-Lafourcade BM, Page AL, et al.
2010-06-11 • PLOS One
2010-06-11 • PLOS One
Meningococcal meningitis outbreaks occur every year during the dry season in the "meningitis belt" of sub-Saharan Africa. Identification of the causative strain is crucial before launchi...
Rose AMC, Gerstl S, Mahamane AE, Sidikou F, Djibo S, et al.
2009-10-05 • PLOS One
2009-10-05 • PLOS One
The Pastorex((R)) (BioRad) rapid agglutination test is one of the main rapid diagnostic tests (RDTs) for meningococcal disease currently in use in the "meningitis belt". Earlier evaluati...
2018-05-07 • Proceedings of the National Academy of Sciences
2018-05-07 • Proceedings of the National Academy of Sciences
In the African meningitis belt, a region of sub-Saharan Africa comprising 22 countries from Senegal in the west to Ethiopia in the east, large epidemics of serogroup A meningococcal meni...
Nathan N, Rose AMC, Legros D, Tiendrebeogo SRM, Bachy C, et al.
2007-06-01 • Emerging Infectious Diseases
2007-06-01 • Emerging Infectious Diseases
In 2002, the largest epidemic of Neisseria meningitidis serogroup W135 occurred in Burkina Faso. The highest attack rate was in children <5 years of age. We describe cases from 1 distric...
Guerin PJ, Naess LM, Fogg C, Rosenqvist E, Pinoges LLP, et al.
2008-12-02 • PLOS Neglected Tropical Diseases
2008-12-02 • PLOS Neglected Tropical Diseases
BACKGROUND: Neisseria meningitidis serogroup A is the main causative pathogen of meningitis epidemics in sub-Saharan Africa. In recent years, serogroup W135 has also been the cause of ep...
Funk A, Uadiale K, Kamau C, Caugant DA, Ango U, et al.
2014-12-29 • PLoS Currents
2014-12-29 • PLoS Currents
The Democratic Republic of Congo (DRC) has committed to eliminate measles by 2020. In 2013, in response to a large outbreak, Médecins Sans Frontières conducted a mass vaccination campaig...
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated...
Barnes GK, Naess LM, Rosenqvist E, Guerin PJ, Caugant DA
2011-06-08 • Scandinavian Journal of Immunology
2011-06-08 • Scandinavian Journal of Immunology
In the absence of an affordable conjugate meningococcal vaccine, mass vaccination campaigns with polysaccharide vaccines are the means to control meningitis epidemics in sub-Saharan Afri...
Uadiale K, Bestman A, Kamau C, Caugant DA, Greig J
2016-07-01 • Transactions of the Royal Society of Tropical Medicine and Hygiene
2016-07-01 • Transactions of the Royal Society of Tropical Medicine and Hygiene
Neisseria meningitidis serogroup C (NmC) has caused outbreaks in Nigeria of increasing size in three consecutive years since 2013. Rapid diagnostic tests (RDTs) for meningitis can facili...
2017-12-15 • Tropical Medicine and International Health
2017-12-15 • Tropical Medicine and International Health
Daugla DM, Gami JP, Gamougam K, Naibei N, Mbainadji L, et al.
2014-01-04 • Lancet
2014-01-04 • Lancet
A serogroup A meningococcal polysaccharide-tetanus toxoid conjugate vaccine (PsA-TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safe...
